MAP2K7 and neoplasm: Consistent with this observation, tumour growth in the PIK3CA wild-type SW620-bearing xenograft model was gradually reduced response to treatment with the selective MEK inhibitor, AZD6244, whereas tumour growth was not slowed in the PIK3CA mutant DLD-1-bearing xenograft model (Fig. 1e, f).